SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-206477
Filing Date
2021-07-01
Accepted
2021-07-01 17:00:59
Documents
14
Period of Report
2021-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d50384d8k.htm   iXBRL 8-K 41848
2 EX-10.1 d50384dex101.htm EX-10.1 859717
3 EX-10.2 d50384dex102.htm EX-10.2 592317
  Complete submission text file 0001193125-21-206477.txt   1959115

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20210701.xsd EX-101.SCH 2888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20210701_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20210701_pre.xml EX-101.PRE 10950
7 EXTRACTED XBRL INSTANCE DOCUMENT d50384d8k_htm.xml XML 3273
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 211066752
SIC: 2834 Pharmaceutical Preparations